Proposed changes to research and development tax incentive will discourage investment and undermine innovation

6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...

Read more →

Taxpayers are funding expensive drug development, report says

10 May 2019 - The Dutch government invests tens of millions of euros every year in small biotech companies which ...

Read more →

Medicines Australia welcomes ALP R&D investment pledge

8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...

Read more →

VAT cut on ‘orphan drugs’ will lift healthcare burden, but many still struggle to afford medication

24 March 2019 - China has reduced value-added tax (VAT) by 3% on 21 orphan drugs and four active pharmaceutical ingredients ...

Read more →

Pharma companies avoid estimated $215m a year in local tax: Oxfam

18 September 2018 - Pharmaceutical companies behind some of Australia’s best-known brands avoided an estimated $215 million a year in ...

Read more →

Survey shows public support for NHS tax rise

5 July 2018 - The vast majority of the public would be willing to accept tax increases to secure significant ...

Read more →

Tax rises on the horizon for NHS budget hike

19 June 2018 - Prime Minister Theresa May has confirmed that tax rises will be necessary to help fund the ...

Read more →

Medical research caught in cross-fire of R&D tax overhaul

9 April 2018 - Industry commercialising medical research caught in cross-fire of R&D tax overhaul. ...

Read more →

AusBiotech says plan to disadvantage life sciences innovation

6 February 2018 - Response to Innovation and Science Australia 2030 plan. ...

Read more →

More Government tax incentives for health insurance?

30 January 2018 - While in the real world consumers struggle to meet private health care costs, health funds are ...

Read more →